Cidara Therapeutics Inc
F:20D0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cidara Therapeutics Inc
F:20D0
|
US |
|
H
|
Helmerich and Payne Inc
XMUN:HPC
|
US |
|
AxoGen Inc
F:LT3
|
US |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Cidara Therapeutics Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Cidara Therapeutics Does
Cidara Therapeutics, Inc. is a biotechnology company, which engages in the discovery, development, and commercialization of novel anti-infectives. The company is headquartered in San Diego, California and currently employs 89 full-time employees. The company went IPO on 2015-04-15. The firm is focused on the discovery, development and commercialization of therapeutics designed for the care of patients facing serious fungal or viral infections.
- Headquarters
- United States of America US
- Employees
- 89
- IPO date
- Apr 15, 2015
Cidara Therapeutics has no economic moat
Cidara Therapeutics Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.
Read the full moat analysis